GPT and Cirrhosis: In the secondary analyses, which focused on the treatment-naïve pwHBV, the differences in the proportions of participants with fibrosis and cirrhosis between HBV DNA and ALT groups were similar to those from the main analyses (Table S2, Supplementary Materials).